Mercy South is a clinical research site located in St Louis, Missouri, United States 63128.
Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.
Mercy South has participated in 6 clinical trials with 5 currently active.
Therapeutic areas: Advanced Non-Small Cell Lung Cancer, Cardiovascular Disease and Lipoprotein(a), Resectable Non-small Cell Lung Cancer.
Sponsors: Regeneron Pharmaceuticals, Novartis Pharmaceuticals, ReFlow Medical, Inc..
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Missouri · View every site in St Louis
Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Mercy South has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Mercy South has 6 clinical trials on record, with 5 currently active. Their work covers Advanced Non-Small Cell Lung Cancer, Cardiovascular Disease and Lipoprotein(a), Resectable Non-small Cell Lung Cancer.
Mercy South has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.